Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

144 PROCARE – phase 2 KCE reports 81LATE GRADE 4 COMPLICATIONS OF RADIOTHERAPY ORCHEMORADIATIONMeasurement in prospective PROCARE database (Figure 54)Patients receiving radio(chemo)therapy are selected with variables ‘AD_V113’,‘AD_V114’, ‘AD_V117’, ‘AD_V118’, ‘AD_V121’ and ‘AD_V122’. Late complications ofradio(chemo)therapy are registered with variables ‘FU_V106’ – ‘FU_V110’.Measurement in coupled administrative databaseNo specific administrative codes are available for late (C)RT-related complications. Inthe ICD-9-CM coding system some aspecific codes are available (990 effects ofradiation, unspecified; 963.1 poisoning by primarily systemic agents: antineoplastic andimmunosuppressive drugs; 558.1 gastroenteritis and colitis due to radiation; etc.), butthere is no mentioning of grade. Therefore, these codes cannot be used. The QI is notmeasurable.Figure 54. Algorithm for QI 1263 (prospective database).All patientsN=1071Radio and/orchemotherapyFollow-updata after 1 yearGRADE 4 OR 5N=771 N=112N=10,97%GRADE 0-1-2-3Radioand/orchemotherapy?Follow-up dataavailable?Gradecomplications?N=17Gradecomplications= MISSINGN=9No follow up dataafter 1 yearN=633No radio and/orchemotherapyN=300Follow-updata after 1 yearN=26No complicationsN=85USE OF THE PATHOLOGY REPORT SHEETMeasurement in prospective PROCARE databaseIn the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Those patients undergoing resectionalsurgery (including local excision or TEMS) are selected using variables ‘SG_V168’,‘SG_V210’, ‘SG_V216’ and ‘SG_V234’. However, no code is available that registers theuse of a pathology report sheet by the pathologist. Also, the suggested pathology reportsheet is only in use since November 2006.Measurement in coupled administrative databaseNo administrative code exists for the use of a pathology report sheet.
KCE Reports 81 PROCARE – phase 2 145QUALITY OF TME ASSESSED ACCORDING TO QUIRKE ANDMENTIONED IN THE PATHOLOGY REPORTMeasurement in prospective PROCARE database (Figure 55)Patients undergoing TME are registered using the variable ‘SG_V210’ in the operativedata section. Within this group of patients, those having a quality assessment of TMEaccording to Quirke are selected with variable ‘PT_V111’ in the pathology section.Measurement in coupled administrative databaseNo administrative code exists for the result of a TME quality assessment, which in factare data that can only be retrieved from the medical file.Figure 55. Algorithm for QI 1272 (prospective database).All patientsN=1071TMESurgeryN=833External surfaceknownN=1058N=25230,25%Surgery?Operationtechniqueused?External surfaceTME filled outExternal surface notknown orMISSINGN=581PMEN=138No surgeryConventionalN=13N=11Operation techniqueMISSINGN=76
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104: KCE Reports 81 PROCARE - phase 2 93
Page 153: KCE Reports 81 PROCARE - phase 2 14
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

Create successful ePaper yourself

Delete template?

Save as template?